FVLTX | VIVIX | FVLTX / VIVIX | |
Total Expense Ratio | 1.40 | 0.04 | 3,500% |
Annual Report Gross Expense Ratio | 1.61 | 0.04 | 4,025% |
Fund Existence | 22 years | 27 years | - |
Gain YTD | 0.644 | 2.452 | 26% |
Front Load | 4% | N/A | - |
Min. Initial Investment | 0 | 5000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 27.7M | 189B | 0% |
Annual Yield % from dividends | 1.13 | 2.29 | 49% |
Returns for 1 year | -6.63 | 8.01 | -83% |
Returns for 3 years | 6.61 | 32.19 | 21% |
Returns for 5 years | 33.60 | 72.56 | 46% |
Returns for 10 years | 24.20 | 103.54 | 23% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
LBWIX | 20.48 | -0.21 | -1.01% |
BrandywineGLOBAL Div US Large Value I | |||
BSPAX | 700.68 | -7.89 | -1.11% |
iShares S&P 500 Index Investor A | |||
MGGLX | 35.39 | -0.55 | -1.53% |
Morgan Stanley Inst Global Opp L | |||
LRSRX | 12.56 | -0.25 | -1.95% |
Lord Abbett Small Cap Value R3 | |||
MREGX | 14.59 | -0.29 | -1.95% |
BlackRock Unconstrained Equity R |